ROS & Cancer: Why “Antioxidants Prevent Cancer” is Too Simple (and How Tumors Use Oxidation to Survive)

ROS & Cancer: Why “Antioxidants Prevent Cancer” is Too Simple (and How Tumors Use Oxidation to Survive)

Reactive oxygen species (ROS) sit at the center of modern cancer biology and the conversation around them is often wildly oversimplified. In this Deep Dive, Dr. Mike Belkowski explains why ROS are not “bad molecules,” but cellular signaling messengers that can be hijacked by tumors. The core framework is the one you need to remember: ROS has a dual role in cancer —moderate ROS can support tumor growth and therapy resistance, while excessive ROS can push cancer cells into programmed death (including ferroptosis).

You’ll learn the major ROS species (signaling vs damage), where ROS comes from (mitochondria, peroxisomes, ER, NOX enzymes + environmental sources), how tumors walk a redox tightrope using NRF2 to stay below toxic thresholds, and how redox biology controls angiogenesis, metastasis, drug resistance, and immune evasion. Finally, the episode lands on the mature therapeutic vision: personalized redox oncology — profiling a tumor’s “redox signature” to decide when to inhibit ROS signaling vs when to push ROS past the cancer cell’s tolerance threshold, often in combination with standard therapy.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications

-

Key Quotes From Dr. Mike:

“ROS have a dual role in cancer."

“Moderate ROS can help tumors grow and resist therapy, while excessive ROS can push cancer cells into programmed cell death.”

“Mitochondria are not just energy factories, they’re redox generators and redox regulators.”

“The future vision is personalized redox oncology.”

“Cancer is a redox game.”

-

Key Points

  • ROS are signaling molecules, not just damage molecules; cancer hijacks the signaling.

  • Dual role: moderate ROS = pro-growth + resistance; excessive ROS = cell death.

  • Hydrogen peroxide (H₂O₂) is a key signaling ROS; hydroxyl radicals are the damage ROS.

  • Major endogenous sources: mitochondria (Complex I/III leak), peroxisomes, ER protein folding, NOX enzymes.

  • Redox balance is governed by NRF2 — protective in healthy cells, often weaponized by tumors.

  • Tumors live on a redox tightrope: high enough ROS to drive survival pathways, low enough to avoid self-destruction.

  • Moderate ROS can amplify survival networks (MAPK/ERK, PI3K-AKT-mTOR, HIF-1α, NF-κB, JAK-STAT, TGF-β).

  • Excess ROS can activate death programs: apoptosis, autophagy-dependent death, ferroptosis (iron + lipid peroxidation).

  • ROS shapes the tumor ecosystem: angiogenesis, metastasis programs, drug efflux/NRF2 detox capacity, immune suppression (e.g., PD-L1).

  • Two therapeutic directions: reduce pro-tumor ROS signaling or push ROS over the threshold—the hard part is selectivity.

  • Future: redox signatures + precision combinations to increase kill rates and reduce resistance.

-

Episode timeline

  • 0:19–1:39 — Why ROS is central to cancer; “ROS is both a fuel and a weapon”

  • 1:50–3:23 — ROS defined + species differences (H₂O₂ signaling vs hydroxyl damage; superoxide upstream)

  • 3:23–6:59 — ROS sources: mitochondria, peroxisomes, ER, NOX + exogenous exposures and immune “respiratory burst”

  • 6:59–9:10 — Redox homeostasis + NRF2/KEAP1; tumors hijack NRF2 to survive the tightrope

  • 9:10–11:24 — How moderate ROS drives cancer: DNA damage + pro-survival signaling networks

  • 11:24–12:04 — Ferroptosis explained: lipid peroxidation as a kill-switch strategy

  • 12:04–13:55 — Clinical layers ROS influences: angiogenesis, metastasis, drug resistance, immune suppression

  • 13:55–16:17 — Therapeutic implications: lower ROS signaling vs pro-oxidant push; selectivity problem

  • 16:17–17:18 — “Energy Code” interpretation: targeted redox imbalance, not moral narratives

  • 17:18–18:20 — Audience takeaways (clinicians, biohackers, builders); one-line summary

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight:

Website

Instagram

YouTube

Facebook

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(381)

Mitochondrial Medicine Is Accelerating: 8 New Breakthroughs You Need to Know

Mitochondrial Medicine Is Accelerating: 8 New Breakthroughs You Need to Know

Light just won the Nobel Prize — and at virtually the same time, mitochondrial science is exploding with new discoveries. In this solo episode of The Energy Code, Dr. Mike Belkowski breaks down some o...

8 Okt 55min

Beyond Mitochondria: The Invisible Energy System Running Your Body | Harry Massey

Beyond Mitochondria: The Invisible Energy System Running Your Body | Harry Massey

What if human health is governed by more than chemistry alone? In this episode of The Energy Code, Dr. Mike Belkowski sits down with Harry Massey, pioneer in bioenergetics and founder of NES Health an...

1 Okt 1h 12min

The Missing Link That Could Make Every Peptide Work Better

The Missing Link That Could Make Every Peptide Work Better

Why do some people experience incredible results from peptides while others barely notice a difference? In this episode of The Energy Code, Dr. Mike Belkowski and Don Bailey explore one of the most ov...

24 Sep 1h 25min

The Biggest Peptide Breakthroughs of 2026: MOTS-c, Retatrutide, FDA Shifts & What Happens Next

The Biggest Peptide Breakthroughs of 2026: MOTS-c, Retatrutide, FDA Shifts & What Happens Next

The peptide landscape is evolving faster than ever before — and 2026 may prove to be the biggest turning point yet. In this episode, Dr. Mike Belkowski breaks down the most important developments shap...

17 Sep 34min

The Light System Explained: Can Light, Frequency & Energy Transform Your Health? | Jarrod Barakett

The Light System Explained: Can Light, Frequency & Energy Transform Your Health? | Jarrod Barakett

In this special episode of The Energy Code, Dr. Mike Belkowski sits down with Jarrod Barakett, President of The Light System, to explore the intersection of light frequencies, bioenergetics, cellular ...

10 Sep 1h 13min

10 Breakthrough Mitochondrial Studies That Could Change Medicine Forever

10 Breakthrough Mitochondrial Studies That Could Change Medicine Forever

In this special Research Jamboree episode of The Energy Code, Dr. Mike Belkowski takes listeners on a rapid-fire tour through some of the most exciting mitochondrial research published over the past f...

3 Sep 36min

The Ultimate Guide to Intranasal Peptides: Brain Repair, Focus, Sleep, Longevity & More

The Ultimate Guide to Intranasal Peptides: Brain Repair, Focus, Sleep, Longevity & More

Intranasal peptides have become one of the most exciting frontiers in peptide research — but which ones actually make sense, and why? In this episode, Dr. Mike Belkowski breaks down the science behind...

27 Aug 1h 3min

GLP-1s, Urolithin A & Urolithin B: Uncovering the Mitochondria-Metabolism-Brain Axis

GLP-1s, Urolithin A & Urolithin B: Uncovering the Mitochondria-Metabolism-Brain Axis

Could metabolic aging, chronic anxiety, and depression all share the same biological root? In this episode of The Energy Code, Dr. Mike Belkowski reviews three newly published studies that, when viewe...

20 Aug 45min

Populärt inom Hälsa

somna-med-henrik
rss-bara-en-till-om-beroende-medberoende
rss-jossan-nina
inga-beiga-morsor
rss-vuxna-pa-latsas
bullfika
rss-viktmedicinpodden
sexnoveller-deluxe
johannes-hansen-podcast
not-fanny-anymore
rss-ronden
sova-med-dan-horning
sa-in-i-sjalen
rss-i-skallen-pa
angestpodden
tyngre-traningssnack
rss-hos-psykologen
brottarbroder
rss-basta-livet
medicinvetarna